subject: CHEBI:31355

object_name: Small intestine carcinoma recurrent


subject: CHEBI:31355

subject_name: Carboplatin

object_name: PPoma

tested_intervention: unsure


subject: CHEBI:31355

object_name: Testis cancer recurrent


subject: CHEBI:31355

object_name: stage III testicular cancer


subject: CHEBI:31355

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: stage IV pancreatic cancer


subject: CHEBI:31355

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:31355

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:31355

object_name: Pancreatic carcinoma stage III


subject: CHEBI:31355

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:31355

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:31355

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IV Bladder Cancer AJCC v7


subject: CHEBI:31355

object_name: Bladder cancer stage IV


subject: CHEBI:31355

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:31355

object_name: Endometrial cancer stage III


subject: CHEBI:31355

object_name: Recurrent Endometrial Cancer


subject: CHEBI:31355

object_name: Bladder cancer recurrent


subject: CHEBI:31355

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:31355

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:31355

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:31355

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:31355

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:31355

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:31355

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:31355

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:31355

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:31355

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:31355

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:31355

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:31355

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:31355

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:31355

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:31355

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:31355

object_name: Colon cancer recurrent


subject: CHEBI:31355

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage III Colon Cancer


subject: CHEBI:31355

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Recurrent Cancer of Gallbladder


subject: CHEBI:31355

object_name: Malignant neoplasm of gallbladder recurrent


subject: CHEBI:31355

object_name: Vulval cancer metastatic


subject: CHEBI:31355

object_name: Stage IVB Vulvar Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: CHEBI:31355

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:31355

object_name: Stage III Vulvar Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage III Vulvar Cancer AJCC v7


subject: CHEBI:31355

object_name: Vulval cancer stage III


subject: CHEBI:31355

object_name: Stage III Vulvar Cancer AJCC v6


subject: CHEBI:31355

object_name: Breast cancer recurrent


subject: CHEBI:31355

object_name: Recurrent Vulvar Carcinoma


subject: CHEBI:31355

object_name: Salivary gland cancer stage IV


subject: CHEBI:31355

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:31355

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:31355

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:31355

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:31355

object_name: Salivary gland cancer stage III


subject: CHEBI:31355

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:31355

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:31355

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:31355

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: CHEBI:31355

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: CHEBI:31355

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:31355

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:31355

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:31355

object_name: stage III papillary thyroid cancer


subject: CHEBI:31355

object_name: Malignant neoplasm of stomach stage III


subject: CHEBI:31355

object_name: recurrent gastric cancer


subject: CHEBI:31355

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8

tested_intervention: yes


subject: CHEBI:31355

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:31355

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:31355

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:31355

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:31355

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:31355

object_name: inflammatory breast carcinoma


subject: CHEBI:31355

object_name: Recurrent Parathyroid Gland Carcinoma


subject: CHEBI:31355

object_name: Metastatic Parathyroid Gland Carcinoma


subject: CHEBI:31355

object_name: recurrent islet cell carcinoma


subject: CHEBI:31355

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:31355

object_name: newly diagnosed carcinoma of unknown primary


subject: CHEBI:31355

object_name: lung carcinoid tumor


subject: CHEBI:31355

object_name: Recurrent Carcinoma of Unknown Primary


subject: CHEBI:31355

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Recurrent Adrenal Cortical Carcinoma


subject: CHEBI:31355

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Malignant pericardial effusion


subject: CHEBI:31355

object_name: small intestine adenocarcinoma


subject: CHEBI:31355

object_name: appendix carcinoma


subject: CHEBI:31355

object_name: medullary thyroid gland carcinoma


subject: CHEBI:31355

object_name: Malignant pleural effusion


subject: CHEBI:31355

object_name: Secondary malignant neoplasm of skin


subject: CHEBI:31355

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: CHEBI:31355

object_name: pancreatic somatostatinoma


subject: CHEBI:31355

object_name: somatostatinoma


subject: CHEBI:31355

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:31355

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:31355

object_name: WDHA Syndrome


subject: CHEBI:31355

object_name: VIPoma


subject: CHEBI:31355

object_name: glucagonoma


subject: CHEBI:31355

object_name: Zollinger-Ellison syndrome


subject: CHEBI:31355

object_name: gastrinoma


subject: CHEBI:31355

object_name: pancreatic gastrinoma


subject: CHEBI:31355

object_name: insulinoma


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:231601

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:231601

object_name: Renal cell carcinoma recurrent


subject: CHEBI:231601

object_name: Renal cancer recurrent


subject: CHEBI:231601

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage III renal cell cancer


subject: CHEBI:231601

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:231601

object_name: Anal cancer stage IV


subject: CHEBI:231601

object_name: Stage IV Anal Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Anal cancer recurrent


subject: CHEBI:231601

object_name: Stage IIIA Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Stage IIIA Anal Cancer AJCC v8


subject: CHEBI:231601

object_name: stage IIIA anal cancer


subject: CHEBI:231601

object_name: Stage IIIB Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: stage IIIB anal cancer


subject: CHEBI:231601

object_name: Stage IIIB Anal Cancer AJCC v8


subject: CHEBI:231601

object_name: stage III vaginal cancer


subject: CHEBI:231601

object_name: Stage III Vaginal Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage III Vaginal Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Vaginal cancer recurrent


subject: CHEBI:231601

object_name: stage IVA vaginal cancer


subject: CHEBI:231601

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage IVA Vaginal Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage IVB Vaginal Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:231601

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: CHEBI:231601

object_name: Distal Urethral Carcinoma


subject: CHEBI:231601

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:231601

object_name: Rectal cancer stage IV


subject: CHEBI:231601

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:231601

object_name: posterior urethra cancer


subject: CHEBI:231601

object_name: Proximal Urethral Carcinoma


subject: CHEBI:231601

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:231601

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:231601

object_name: stage III cervical cancer


subject: CHEBI:231601

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Stage III Cervical Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Cervical carcinoma stage IVA


subject: CHEBI:231601

object_name: Cervical carcinoma stage IVB


subject: CHEBI:231601

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:231601

object_name: Recurrent Urethral Cancer


subject: CHEBI:231601

object_name: Cervix carcinoma recurrent


subject: CHEBI:231601

object_name: advanced adult primary liver cancer


subject: CHEBI:231601

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:231601

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:231601

object_name: stage IV esophageal cancer


subject: CHEBI:231601

object_name: Recurrent Adult Liver Carcinoma


subject: CHEBI:231601

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Ovarian cancer stage IV


subject: CHEBI:231601

object_name: fallopian tube carcinoma


subject: CHEBI:231601

object_name: fallopian tube cancer


subject: CHEBI:231601

object_name: Stage III Esophageal Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage III Esophageal Cancer


subject: CHEBI:231601

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:231601

object_name: Ovarian cancer stage III


subject: CHEBI:231601

object_name: Recurrent ovarian cancer


subject: CHEBI:231601

object_name: urethral carcinoma associated with invasive bladder cancer


subject: CHEBI:231601

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:231601

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:231601

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:231601

object_name: Carcinoma of the prostate stage III


subject: CHEBI:231601

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:231601

object_name: Prostate cancer recurrent


subject: CHEBI:231601

object_name: Occult Lung Non-Small Cell Carcinoma


subject: CHEBI:231601

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:231601

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:231601

object_name: male breast carcinoma


subject: CHEBI:231601

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:231601

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:231601

object_name: Small intestine carcinoma recurrent


subject: CHEBI:231601

object_name: PPoma


subject: CHEBI:231601

object_name: Testis cancer recurrent


subject: CHEBI:231601

object_name: stage III testicular cancer


subject: CHEBI:231601

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: stage IV pancreatic cancer


subject: CHEBI:231601

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:231601

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:231601

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:231601

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:231601

object_name: Pancreatic carcinoma stage III


subject: CHEBI:231601

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:231601

object_name: peritoneum cancer


subject: CHEBI:231601

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:231601

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage IV Bladder Cancer AJCC v7


subject: CHEBI:231601

object_name: Bladder cancer stage IV


subject: CHEBI:231601

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:231601

object_name: Endometrial cancer stage III


subject: CHEBI:231601

object_name: Recurrent Endometrial Cancer


subject: CHEBI:231601

object_name: Bladder cancer recurrent


subject: CHEBI:231601

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:231601

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:231601

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:231601

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:231601

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:231601

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:231601

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:231601

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231601

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:231601

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:231601

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:231601

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:231601

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231601

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:231601

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:231601

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:231601

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:231601

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:231601

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage III Colon Cancer


subject: CHEBI:231601

object_name: Recurrent Cancer of Gallbladder


subject: CHEBI:231601

object_name: Malignant neoplasm of gallbladder recurrent


subject: CHEBI:231601

object_name: Vulval cancer metastatic


subject: CHEBI:231601

object_name: Stage IVB Vulvar Cancer AJCC v6 and v7


subject: CHEBI:231601

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage III Vulvar Cancer AJCC v8


subject: CHEBI:231601

object_name: Stage III Vulvar Cancer AJCC v7


subject: CHEBI:231601

object_name: Vulval cancer stage III


subject: CHEBI:231601

object_name: Stage III Vulvar Cancer AJCC v6


subject: CHEBI:231601

object_name: Recurrent Vulvar Carcinoma


subject: CHEBI:231601

object_name: Salivary gland cancer stage IV


subject: CHEBI:231601

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:231601

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:231601

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:231601

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:231601

object_name: Salivary gland cancer stage III


subject: CHEBI:231601

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:231601

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:231601

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:231601

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: CHEBI:231601

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: CHEBI:231601

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:231601

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:231601

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:231601

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:231601

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:231601

object_name: stage III papillary thyroid cancer


subject: CHEBI:231601

object_name: Malignant neoplasm of stomach stage III


subject: CHEBI:231601

object_name: recurrent gastric cancer


subject: CHEBI:231601

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:231601

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:231601

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:231601

object_name: Recurrent Parathyroid Gland Carcinoma


subject: CHEBI:231601

object_name: Metastatic Parathyroid Gland Carcinoma


subject: CHEBI:231601

object_name: recurrent islet cell carcinoma


subject: CHEBI:231601

object_name: newly diagnosed carcinoma of unknown primary


subject: CHEBI:231601

object_name: lung carcinoid tumor


subject: CHEBI:231601

object_name: Recurrent Carcinoma of Unknown Primary


subject: CHEBI:231601

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:231601

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:231601

object_name: Recurrent Adrenal Cortical Carcinoma


subject: CHEBI:231601

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:231601

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:231601

object_name: Malignant pericardial effusion


subject: CHEBI:231601

object_name: small intestine adenocarcinoma


subject: CHEBI:231601

object_name: appendix carcinoma


subject: CHEBI:231601

object_name: medullary thyroid gland carcinoma


subject: CHEBI:231601

object_name: Malignant pleural effusion


subject: CHEBI:231601

object_name: Secondary malignant neoplasm of skin


subject: CHEBI:231601

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: CHEBI:231601

object_name: pancreatic somatostatinoma


subject: CHEBI:231601

object_name: somatostatinoma


subject: CHEBI:231601

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:231601

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:231601

object_name: WDHA Syndrome


subject: CHEBI:231601

object_name: VIPoma


subject: CHEBI:231601

object_name: glucagonoma


subject: CHEBI:231601

object_name: Zollinger-Ellison syndrome


subject: CHEBI:231601

object_name: gastrinoma


subject: CHEBI:231601

object_name: pancreatic gastrinoma


subject: CHEBI:231601

object_name: insulinoma


subject: UNII:SE2KH7T06F

object_name: Stage IV Renal Cell Cancer


subject: UNII:SE2KH7T06F

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Renal cell carcinoma recurrent


subject: UNII:SE2KH7T06F

object_name: Renal cancer recurrent


subject: UNII:SE2KH7T06F

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage III renal cell cancer


subject: UNII:SE2KH7T06F

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Anal cancer stage IV


subject: UNII:SE2KH7T06F

object_name: Stage IV Anal Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Anal cancer recurrent


subject: UNII:SE2KH7T06F

object_name: Stage IIIA Anal Canal Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Stage IIIA Anal Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: stage IIIA anal cancer


subject: UNII:SE2KH7T06F

object_name: Stage IIIB Anal Canal Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: stage IIIB anal cancer


subject: UNII:SE2KH7T06F

object_name: Stage IIIB Anal Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: stage III vaginal cancer


subject: UNII:SE2KH7T06F

object_name: Stage III Vaginal Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage III Vaginal Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Vaginal cancer recurrent


subject: UNII:SE2KH7T06F

object_name: stage IVA vaginal cancer


subject: UNII:SE2KH7T06F

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IVA Vaginal Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IVB Vaginal Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: UNII:SE2KH7T06F

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: UNII:SE2KH7T06F

object_name: Distal Urethral Carcinoma


subject: UNII:SE2KH7T06F

object_name: Stage IV Rectal Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Rectal cancer stage IV


subject: UNII:SE2KH7T06F

object_name: Stage IV Rectal Cancer AJCC v6


subject: UNII:SE2KH7T06F

object_name: posterior urethra cancer


subject: UNII:SE2KH7T06F

object_name: Proximal Urethral Carcinoma


subject: UNII:SE2KH7T06F

object_name: Stage III Rectal Cancer AJCC v6


subject: UNII:SE2KH7T06F

object_name: Stage III Rectal Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: stage III cervical cancer


subject: UNII:SE2KH7T06F

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Stage III Cervical Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Cervical carcinoma stage IVA


subject: UNII:SE2KH7T06F

object_name: Cervical carcinoma stage IVB


subject: UNII:SE2KH7T06F

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Recurrent Urethral Cancer


subject: UNII:SE2KH7T06F

object_name: Cervix carcinoma recurrent


subject: UNII:SE2KH7T06F

object_name: advanced adult primary liver cancer


subject: UNII:SE2KH7T06F

object_name: Stage IV Esophageal Cancer AJCC v6


subject: UNII:SE2KH7T06F

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: stage IV esophageal cancer


subject: UNII:SE2KH7T06F

object_name: Recurrent Adult Liver Carcinoma


subject: UNII:SE2KH7T06F

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Ovarian cancer stage IV


subject: UNII:SE2KH7T06F

object_name: fallopian tube carcinoma


subject: UNII:SE2KH7T06F

object_name: fallopian tube cancer


subject: UNII:SE2KH7T06F

object_name: Stage III Esophageal Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage III Esophageal Cancer


subject: UNII:SE2KH7T06F

object_name: Oesophageal carcinoma recurrent


subject: UNII:SE2KH7T06F

object_name: Ovarian cancer stage III


subject: UNII:SE2KH7T06F

object_name: Recurrent ovarian cancer


subject: UNII:SE2KH7T06F

object_name: urethral carcinoma associated with invasive bladder cancer


subject: UNII:SE2KH7T06F

object_name: Stage IV Prostate Cancer AJCC v6


subject: UNII:SE2KH7T06F

object_name: Carcinoma of the prostate stage IV


subject: UNII:SE2KH7T06F

object_name: Stage IV Prostate Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage III Prostate Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage III Prostate Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Carcinoma of the prostate stage III


subject: UNII:SE2KH7T06F

object_name: Stage III Prostate Cancer AJCC v6


subject: UNII:SE2KH7T06F

object_name: Prostate cancer recurrent


subject: UNII:SE2KH7T06F

object_name: Occult Lung Non-Small Cell Carcinoma


subject: UNII:SE2KH7T06F

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UNII:SE2KH7T06F

object_name: Non-small cell lung cancer recurrent


subject: UNII:SE2KH7T06F

object_name: male breast carcinoma


subject: UNII:SE2KH7T06F

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:SE2KH7T06F

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:SE2KH7T06F

object_name: Small intestine carcinoma recurrent


subject: UNII:SE2KH7T06F

object_name: PPoma


subject: UNII:SE2KH7T06F

object_name: Testis cancer recurrent


subject: UNII:SE2KH7T06F

object_name: stage III testicular cancer


subject: UNII:SE2KH7T06F

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: stage IV pancreatic cancer


subject: UNII:SE2KH7T06F

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UNII:SE2KH7T06F

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Pancreatic carcinoma stage III


subject: UNII:SE2KH7T06F

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Pancreatic carcinoma recurrent


subject: UNII:SE2KH7T06F

object_name: peritoneum cancer


subject: UNII:SE2KH7T06F

object_name: Metastatic Endometrial Carcinoma


subject: UNII:SE2KH7T06F

object_name: Stage IV Bladder Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IV Bladder Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Bladder cancer stage IV


subject: UNII:SE2KH7T06F

object_name: Stage IV Bladder Cancer AJCC v6


subject: UNII:SE2KH7T06F

object_name: Endometrial cancer stage III


subject: UNII:SE2KH7T06F

object_name: Recurrent Endometrial Cancer


subject: UNII:SE2KH7T06F

object_name: Bladder cancer recurrent


subject: UNII:SE2KH7T06F

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Stage III Bladder Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UNII:SE2KH7T06F

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:SE2KH7T06F

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:SE2KH7T06F

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UNII:SE2KH7T06F

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UNII:SE2KH7T06F

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UNII:SE2KH7T06F

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:SE2KH7T06F

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:SE2KH7T06F

object_name: Laryngeal squamous cell carcinoma stage III


subject: UNII:SE2KH7T06F

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UNII:SE2KH7T06F

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IV Colon Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IV Colon Cancer AJCC v6


subject: UNII:SE2KH7T06F

object_name: Malignant neoplasm of colon stage IV


subject: UNII:SE2KH7T06F

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: UNII:SE2KH7T06F

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UNII:SE2KH7T06F

object_name: metastatic gastrointestinal carcinoid tumor


subject: UNII:SE2KH7T06F

object_name: Stage III Colon Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage III Colon Cancer


subject: UNII:SE2KH7T06F

object_name: Recurrent Cancer of Gallbladder


subject: UNII:SE2KH7T06F

object_name: Malignant neoplasm of gallbladder recurrent


subject: UNII:SE2KH7T06F

object_name: Vulval cancer metastatic


subject: UNII:SE2KH7T06F

object_name: Stage IVB Vulvar Cancer AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage III Vulvar Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage III Vulvar Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Vulval cancer stage III


subject: UNII:SE2KH7T06F

object_name: Stage III Vulvar Cancer AJCC v6


subject: UNII:SE2KH7T06F

object_name: Recurrent Vulvar Carcinoma


subject: UNII:SE2KH7T06F

object_name: Salivary gland cancer stage IV


subject: UNII:SE2KH7T06F

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: UNII:SE2KH7T06F

object_name: Unresectable Gallbladder Carcinoma


subject: UNII:SE2KH7T06F

object_name: Salivary gland cancer stage III


subject: UNII:SE2KH7T06F

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: UNII:SE2KH7T06F

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: UNII:SE2KH7T06F

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: UNII:SE2KH7T06F

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: UNII:SE2KH7T06F

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: UNII:SE2KH7T06F

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: UNII:SE2KH7T06F

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: UNII:SE2KH7T06F

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: UNII:SE2KH7T06F

object_name: stage III papillary thyroid cancer


subject: UNII:SE2KH7T06F

object_name: Malignant neoplasm of stomach stage III


subject: UNII:SE2KH7T06F

object_name: recurrent gastric cancer


subject: UNII:SE2KH7T06F

object_name: Recurrent Thyroid Carcinoma


subject: UNII:SE2KH7T06F

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: UNII:SE2KH7T06F

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Parathyroid Gland Carcinoma


subject: UNII:SE2KH7T06F

object_name: Metastatic Parathyroid Gland Carcinoma


subject: UNII:SE2KH7T06F

object_name: recurrent islet cell carcinoma


subject: UNII:SE2KH7T06F

object_name: newly diagnosed carcinoma of unknown primary


subject: UNII:SE2KH7T06F

object_name: lung carcinoid tumor


subject: UNII:SE2KH7T06F

object_name: Recurrent Carcinoma of Unknown Primary


subject: UNII:SE2KH7T06F

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: UNII:SE2KH7T06F

object_name: Recurrent Adrenal Cortical Carcinoma


subject: UNII:SE2KH7T06F

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: UNII:SE2KH7T06F

object_name: Malignant pericardial effusion


subject: UNII:SE2KH7T06F

object_name: small intestine adenocarcinoma


subject: UNII:SE2KH7T06F

object_name: appendix carcinoma


subject: UNII:SE2KH7T06F

object_name: medullary thyroid gland carcinoma


subject: UNII:SE2KH7T06F

object_name: Malignant pleural effusion


subject: UNII:SE2KH7T06F

object_name: Secondary malignant neoplasm of skin


subject: UNII:SE2KH7T06F

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: UNII:SE2KH7T06F

object_name: pancreatic somatostatinoma


subject: UNII:SE2KH7T06F

object_name: somatostatinoma


subject: UNII:SE2KH7T06F

object_name: Secondary malignant neoplasm of lung


subject: UNII:SE2KH7T06F

object_name: Metastatic malignant neoplasm to bone


subject: UNII:SE2KH7T06F

object_name: WDHA Syndrome


subject: UNII:SE2KH7T06F

object_name: VIPoma


subject: UNII:SE2KH7T06F

object_name: glucagonoma


subject: UNII:SE2KH7T06F

object_name: Zollinger-Ellison syndrome


subject: UNII:SE2KH7T06F

object_name: gastrinoma


subject: UNII:SE2KH7T06F

object_name: pancreatic gastrinoma


subject: UNII:SE2KH7T06F

object_name: insulinoma


subject: UMLS:C0338204

subject_name: Herceptin

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C0338204

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C0338204

object_name: Renal cell carcinoma recurrent


subject: UMLS:C0338204

object_name: Renal cancer recurrent


subject: UMLS:C0338204

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage III renal cell cancer


subject: UMLS:C0338204

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C0338204

object_name: Anal cancer stage IV


subject: UMLS:C0338204

object_name: Stage IV Anal Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Anal cancer recurrent


subject: UMLS:C0338204

object_name: Stage IIIA Anal Canal Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Stage IIIA Anal Cancer AJCC v8


subject: UMLS:C0338204

object_name: stage IIIA anal cancer


subject: UMLS:C0338204

object_name: Stage IIIB Anal Canal Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: stage IIIB anal cancer


subject: UMLS:C0338204

object_name: Stage IIIB Anal Cancer AJCC v8


subject: UMLS:C0338204

object_name: stage III vaginal cancer


subject: UMLS:C0338204

object_name: Stage III Vaginal Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage III Vaginal Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Vaginal cancer recurrent


subject: UMLS:C0338204

object_name: stage IVA vaginal cancer


subject: UMLS:C0338204

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage IVA Vaginal Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage IVB Vaginal Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: UMLS:C0338204

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: UMLS:C0338204

object_name: Distal Urethral Carcinoma


subject: UMLS:C0338204

object_name: Stage IV Rectal Cancer AJCC v8


subject: UMLS:C0338204

object_name: Rectal cancer stage IV


subject: UMLS:C0338204

object_name: Stage IV Rectal Cancer AJCC v6


subject: UMLS:C0338204

object_name: posterior urethra cancer


subject: UMLS:C0338204

object_name: Proximal Urethral Carcinoma


subject: UMLS:C0338204

object_name: Stage III Rectal Cancer AJCC v6


subject: UMLS:C0338204

object_name: Stage III Rectal Cancer AJCC v8


subject: UMLS:C0338204

object_name: stage III cervical cancer


subject: UMLS:C0338204

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Stage III Cervical Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Cervical carcinoma stage IVA


subject: UMLS:C0338204

object_name: Cervical carcinoma stage IVB


subject: UMLS:C0338204

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UMLS:C0338204

object_name: Recurrent Urethral Cancer


subject: UMLS:C0338204

object_name: Cervix carcinoma recurrent


subject: UMLS:C0338204

object_name: advanced adult primary liver cancer


subject: UMLS:C0338204

object_name: Stage IV Esophageal Cancer AJCC v6


subject: UMLS:C0338204

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UMLS:C0338204

object_name: stage IV esophageal cancer


subject: UMLS:C0338204

object_name: Recurrent Adult Liver Carcinoma


subject: UMLS:C0338204

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Ovarian cancer stage IV


subject: UMLS:C0338204

object_name: fallopian tube carcinoma


subject: UMLS:C0338204

object_name: fallopian tube cancer


subject: UMLS:C0338204

object_name: Stage III Esophageal Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage III Esophageal Cancer


subject: UMLS:C0338204

object_name: Oesophageal carcinoma recurrent


subject: UMLS:C0338204

object_name: Ovarian cancer stage III


subject: UMLS:C0338204

object_name: Recurrent ovarian cancer


subject: UMLS:C0338204

object_name: urethral carcinoma associated with invasive bladder cancer


subject: UMLS:C0338204

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C0338204

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C0338204

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage III Prostate Cancer AJCC v7


subject: UMLS:C0338204

object_name: Carcinoma of the prostate stage III


subject: UMLS:C0338204

object_name: Stage III Prostate Cancer AJCC v6


subject: UMLS:C0338204

object_name: Prostate cancer recurrent


subject: UMLS:C0338204

object_name: Occult Lung Non-Small Cell Carcinoma


subject: UMLS:C0338204

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UMLS:C0338204

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C0338204

object_name: male breast carcinoma


subject: UMLS:C0338204

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C0338204

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C0338204

object_name: Small intestine carcinoma recurrent


subject: UMLS:C0338204

object_name: PPoma


subject: UMLS:C0338204

object_name: Testis cancer recurrent


subject: UMLS:C0338204

object_name: stage III testicular cancer


subject: UMLS:C0338204

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: stage IV pancreatic cancer


subject: UMLS:C0338204

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0338204

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C0338204

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0338204

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C0338204

object_name: Pancreatic carcinoma stage III


subject: UMLS:C0338204

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C0338204

object_name: peritoneum cancer


subject: UMLS:C0338204

object_name: Metastatic Endometrial Carcinoma


subject: UMLS:C0338204

object_name: Stage IV Bladder Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage IV Bladder Cancer AJCC v7


subject: UMLS:C0338204

object_name: Bladder cancer stage IV


subject: UMLS:C0338204

object_name: Stage IV Bladder Cancer AJCC v6


subject: UMLS:C0338204

object_name: Endometrial cancer stage III


subject: UMLS:C0338204

object_name: Recurrent Endometrial Cancer


subject: UMLS:C0338204

object_name: Bladder cancer recurrent


subject: UMLS:C0338204

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C0338204

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UMLS:C0338204

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C0338204

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C0338204

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UMLS:C0338204

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UMLS:C0338204

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UMLS:C0338204

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0338204

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C0338204

object_name: Laryngeal squamous cell carcinoma stage III


subject: UMLS:C0338204

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0338204

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UMLS:C0338204

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0338204

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage IV Colon Cancer AJCC v6


subject: UMLS:C0338204

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C0338204

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: UMLS:C0338204

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UMLS:C0338204

object_name: metastatic gastrointestinal carcinoid tumor


subject: UMLS:C0338204

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage III Colon Cancer


subject: UMLS:C0338204

object_name: Recurrent Cancer of Gallbladder


subject: UMLS:C0338204

object_name: Malignant neoplasm of gallbladder recurrent


subject: UMLS:C0338204

object_name: Vulval cancer metastatic


subject: UMLS:C0338204

object_name: Stage IVB Vulvar Cancer AJCC v6 and v7


subject: UMLS:C0338204

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage III Vulvar Cancer AJCC v8


subject: UMLS:C0338204

object_name: Stage III Vulvar Cancer AJCC v7


subject: UMLS:C0338204

object_name: Vulval cancer stage III


subject: UMLS:C0338204

object_name: Stage III Vulvar Cancer AJCC v6


subject: UMLS:C0338204

object_name: Recurrent Vulvar Carcinoma


subject: UMLS:C0338204

object_name: Salivary gland cancer stage IV


subject: UMLS:C0338204

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UMLS:C0338204

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: UMLS:C0338204

object_name: Recurrent Salivary Gland Cancer


subject: UMLS:C0338204

object_name: Unresectable Gallbladder Carcinoma


subject: UMLS:C0338204

object_name: Salivary gland cancer stage III


subject: UMLS:C0338204

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UMLS:C0338204

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: UMLS:C0338204

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: UMLS:C0338204

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: UMLS:C0338204

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: UMLS:C0338204

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: UMLS:C0338204

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: UMLS:C0338204

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: UMLS:C0338204

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: UMLS:C0338204

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: UMLS:C0338204

object_name: stage III papillary thyroid cancer


subject: UMLS:C0338204

object_name: Malignant neoplasm of stomach stage III


subject: UMLS:C0338204

object_name: recurrent gastric cancer


subject: UMLS:C0338204

object_name: Recurrent Thyroid Carcinoma


subject: UMLS:C0338204

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: UMLS:C0338204

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UMLS:C0338204

object_name: Recurrent Parathyroid Gland Carcinoma


subject: UMLS:C0338204

object_name: Metastatic Parathyroid Gland Carcinoma


subject: UMLS:C0338204

object_name: recurrent islet cell carcinoma


subject: UMLS:C0338204

object_name: newly diagnosed carcinoma of unknown primary


subject: UMLS:C0338204

object_name: lung carcinoid tumor


subject: UMLS:C0338204

object_name: Recurrent Carcinoma of Unknown Primary


subject: UMLS:C0338204

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C0338204

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: UMLS:C0338204

object_name: Recurrent Adrenal Cortical Carcinoma


subject: UMLS:C0338204

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: UMLS:C0338204

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C0338204

object_name: Malignant pericardial effusion


subject: UMLS:C0338204

object_name: small intestine adenocarcinoma


subject: UMLS:C0338204

object_name: appendix carcinoma


subject: UMLS:C0338204

object_name: medullary thyroid gland carcinoma


subject: UMLS:C0338204

object_name: Malignant pleural effusion


subject: UMLS:C0338204

object_name: Secondary malignant neoplasm of skin


subject: UMLS:C0338204

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: UMLS:C0338204

object_name: pancreatic somatostatinoma


subject: UMLS:C0338204

object_name: somatostatinoma


subject: UMLS:C0338204

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C0338204

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C0338204

object_name: WDHA Syndrome


subject: UMLS:C0338204

object_name: VIPoma


subject: UMLS:C0338204

object_name: glucagonoma


subject: UMLS:C0338204

object_name: Zollinger-Ellison syndrome


subject: UMLS:C0338204

object_name: gastrinoma


subject: UMLS:C0338204

object_name: pancreatic gastrinoma


subject: UMLS:C0338204

object_name: insulinoma


subject: UMLS:C1328728

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C1328728

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C1328728

object_name: Renal cell carcinoma recurrent


subject: UMLS:C1328728

object_name: Renal cancer recurrent


subject: UMLS:C1328728

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage III renal cell cancer


subject: UMLS:C1328728

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C1328728

object_name: Anal cancer stage IV


subject: UMLS:C1328728

object_name: Stage IV Anal Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Anal cancer recurrent


subject: UMLS:C1328728

object_name: Stage IIIA Anal Canal Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Stage IIIA Anal Cancer AJCC v8


subject: UMLS:C1328728

object_name: stage IIIA anal cancer


subject: UMLS:C1328728

object_name: Stage IIIB Anal Canal Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: stage IIIB anal cancer


subject: UMLS:C1328728

object_name: Stage IIIB Anal Cancer AJCC v8


subject: UMLS:C1328728

object_name: stage III vaginal cancer


subject: UMLS:C1328728

object_name: Stage III Vaginal Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage III Vaginal Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Vaginal cancer recurrent


subject: UMLS:C1328728

object_name: stage IVA vaginal cancer


subject: UMLS:C1328728

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IVA Vaginal Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IVB Vaginal Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: UMLS:C1328728

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: UMLS:C1328728

object_name: Recurrent Rectal Cancer


subject: UMLS:C1328728

object_name: Distal Urethral Carcinoma


subject: UMLS:C1328728

object_name: Stage IV Rectal Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IV Rectal Cancer AJCC v7


subject: UMLS:C1328728

object_name: Rectal cancer stage IV


subject: UMLS:C1328728

object_name: Stage IV Rectal Cancer AJCC v6


subject: UMLS:C1328728

object_name: posterior urethra cancer


subject: UMLS:C1328728

object_name: Proximal Urethral Carcinoma


subject: UMLS:C1328728

object_name: Stage III Rectal Cancer AJCC v6


subject: UMLS:C1328728

object_name: Stage III Rectal Cancer AJCC v7


subject: UMLS:C1328728

object_name: Stage III Rectal Cancer AJCC v8


subject: UMLS:C1328728

object_name: stage III cervical cancer


subject: UMLS:C1328728

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Stage III Cervical Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Cervical carcinoma stage IVA


subject: UMLS:C1328728

object_name: Cervical carcinoma stage IVB


subject: UMLS:C1328728

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UMLS:C1328728

object_name: Recurrent Urethral Cancer


subject: UMLS:C1328728

object_name: Cervix carcinoma recurrent


subject: UMLS:C1328728

object_name: advanced adult primary liver cancer


subject: UMLS:C1328728

object_name: Stage IV Esophageal Cancer AJCC v6


subject: UMLS:C1328728

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UMLS:C1328728

object_name: stage IV esophageal cancer


subject: UMLS:C1328728

object_name: Recurrent Adult Liver Carcinoma


subject: UMLS:C1328728

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Ovarian cancer stage IV


subject: UMLS:C1328728

object_name: fallopian tube carcinoma


subject: UMLS:C1328728

object_name: fallopian tube cancer


subject: UMLS:C1328728

object_name: Stage III Esophageal Cancer AJCC v7


subject: UMLS:C1328728

object_name: Stage III Esophageal Cancer


subject: UMLS:C1328728

object_name: Oesophageal carcinoma recurrent


subject: UMLS:C1328728

object_name: Ovarian cancer stage III


subject: UMLS:C1328728

object_name: urethral carcinoma associated with invasive bladder cancer


subject: UMLS:C1328728

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C1328728

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C1328728

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C1328728

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage III Prostate Cancer AJCC v7


subject: UMLS:C1328728

object_name: Carcinoma of the prostate stage III


subject: UMLS:C1328728

object_name: Stage III Prostate Cancer AJCC v6


subject: UMLS:C1328728

object_name: Prostate cancer recurrent


subject: UMLS:C1328728

object_name: Occult Lung Non-Small Cell Carcinoma


subject: UMLS:C1328728

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UMLS:C1328728

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C1328728

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C1328728

object_name: male breast carcinoma


subject: UMLS:C1328728

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C1328728

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C1328728

object_name: Small intestine carcinoma recurrent


subject: UMLS:C1328728

object_name: PPoma


subject: UMLS:C1328728

object_name: Testis cancer recurrent


subject: UMLS:C1328728

object_name: stage III testicular cancer


subject: UMLS:C1328728

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: stage IV pancreatic cancer


subject: UMLS:C1328728

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1328728

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C1328728

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1328728

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C1328728

object_name: Pancreatic carcinoma stage III


subject: UMLS:C1328728

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C1328728

object_name: Metastatic Endometrial Carcinoma


subject: UMLS:C1328728

object_name: Stage IV Bladder Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IV Bladder Cancer AJCC v7


subject: UMLS:C1328728

object_name: Bladder cancer stage IV


subject: UMLS:C1328728

object_name: Stage IV Bladder Cancer AJCC v6


subject: UMLS:C1328728

object_name: Endometrial cancer stage III


subject: UMLS:C1328728

object_name: Recurrent Endometrial Cancer


subject: UMLS:C1328728

object_name: Bladder cancer recurrent


subject: UMLS:C1328728

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C1328728

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UMLS:C1328728

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C1328728

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C1328728

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UMLS:C1328728

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UMLS:C1328728

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UMLS:C1328728

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1328728

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C1328728

object_name: Laryngeal squamous cell carcinoma stage III


subject: UMLS:C1328728

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1328728

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UMLS:C1328728

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1328728

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IV Colon Cancer AJCC v6


subject: UMLS:C1328728

object_name: Stage IV Colon Cancer AJCC v7


subject: UMLS:C1328728

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C1328728

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: UMLS:C1328728

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UMLS:C1328728

object_name: metastatic gastrointestinal carcinoid tumor


subject: UMLS:C1328728

object_name: Colon cancer recurrent


subject: UMLS:C1328728

object_name: Stage III Colon Cancer AJCC v7


subject: UMLS:C1328728

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage III Colon Cancer


subject: UMLS:C1328728

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Carcinoma breast stage IV


subject: UMLS:C1328728

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1328728

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1328728

object_name: Recurrent Cancer of Gallbladder


subject: UMLS:C1328728

object_name: Malignant neoplasm of gallbladder recurrent


subject: UMLS:C1328728

object_name: Vulval cancer metastatic


subject: UMLS:C1328728

object_name: Stage IVB Vulvar Cancer AJCC v6 and v7


subject: UMLS:C1328728

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: UMLS:C1328728

object_name: Malignant neoplasm of stomach stage IV


subject: UMLS:C1328728

object_name: Stage III Vulvar Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage III Vulvar Cancer AJCC v7


subject: UMLS:C1328728

object_name: Vulval cancer stage III


subject: UMLS:C1328728

object_name: Stage III Vulvar Cancer AJCC v6


subject: UMLS:C1328728

object_name: Breast cancer recurrent


subject: UMLS:C1328728

object_name: Recurrent Vulvar Carcinoma


subject: UMLS:C1328728

object_name: Salivary gland cancer stage IV


subject: UMLS:C1328728

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UMLS:C1328728

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: UMLS:C1328728

object_name: Recurrent Salivary Gland Cancer


subject: UMLS:C1328728

object_name: Unresectable Gallbladder Carcinoma


subject: UMLS:C1328728

object_name: Salivary gland cancer stage III


subject: UMLS:C1328728

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UMLS:C1328728

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: UMLS:C1328728

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: UMLS:C1328728

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: UMLS:C1328728

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: UMLS:C1328728

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: UMLS:C1328728

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: UMLS:C1328728

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: UMLS:C1328728

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: UMLS:C1328728

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: UMLS:C1328728

object_name: stage III papillary thyroid cancer


subject: UMLS:C1328728

object_name: Malignant neoplasm of stomach stage III


subject: UMLS:C1328728

object_name: recurrent gastric cancer


subject: UMLS:C1328728

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1328728

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C1328728

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C1328728

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1328728

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1328728

object_name: Recurrent Thyroid Carcinoma


subject: UMLS:C1328728

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: UMLS:C1328728

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UMLS:C1328728

object_name: inflammatory breast carcinoma


subject: UMLS:C1328728

object_name: Recurrent Parathyroid Gland Carcinoma


subject: UMLS:C1328728

object_name: Metastatic Parathyroid Gland Carcinoma


subject: UMLS:C1328728

object_name: recurrent islet cell carcinoma


subject: UMLS:C1328728

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C1328728

object_name: newly diagnosed carcinoma of unknown primary


subject: UMLS:C1328728

object_name: lung carcinoid tumor


subject: UMLS:C1328728

object_name: Recurrent Carcinoma of Unknown Primary


subject: UMLS:C1328728

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C1328728

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: UMLS:C1328728

object_name: Recurrent Adrenal Cortical Carcinoma


subject: UMLS:C1328728

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: UMLS:C1328728

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C1328728

object_name: Malignant pericardial effusion


subject: UMLS:C1328728

object_name: small intestine adenocarcinoma


subject: UMLS:C1328728

object_name: appendix carcinoma


subject: UMLS:C1328728

object_name: medullary thyroid gland carcinoma


subject: UMLS:C1328728

object_name: Malignant pleural effusion


subject: UMLS:C1328728

object_name: Secondary malignant neoplasm of skin


subject: UMLS:C1328728

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: UMLS:C1328728

object_name: pancreatic somatostatinoma


subject: UMLS:C1328728

object_name: somatostatinoma


subject: UMLS:C1328728

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C1328728

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C1328728

object_name: WDHA Syndrome


subject: UMLS:C1328728

object_name: VIPoma


subject: UMLS:C1328728

object_name: glucagonoma


subject: UMLS:C1328728

object_name: Zollinger-Ellison syndrome


subject: UMLS:C1328728

object_name: gastrinoma


subject: UMLS:C1328728

object_name: pancreatic gastrinoma


subject: UMLS:C1328728

object_name: insulinoma


subject: PUBCHEM.COMPOUND:25476

subject_name: Angiotensina II

object_name: Sepsis


subject: PUBCHEM.COMPOUND:25476

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:25476

object_name: septic shock


subject: PUBCHEM.COMPOUND:25476

object_name: acute kidney failure


subject: CHEBI:2719

subject_name: Angiotensin II


subject: CHEBI:2719


subject: CHEBI:2719


subject: CHEBI:2719


subject: PR:000036009

subject_name: angiotensin II


subject: PR:000036009


subject: PR:000036009


subject: PR:000036009


subject: UMLS:C5400662

subject_name: Therapeutic Angiotensin II


subject: UMLS:C5400662


subject: UMLS:C5400662


subject: UMLS:C5400662


subject: PUBCHEM.COMPOUND:129678

subject_name: Pelubiprofen

object_name: Acute upper respiratory infection


subject: PUBCHEM.COMPOUND:129678

object_name: Fever


subject: PUBCHEM.COMPOUND:129678

object_name: Fever symptoms (finding)


subject: PUBCHEM.COMPOUND:129678

object_name: Fever, CTCAE


subject: CHEBI:31970


subject: CHEBI:31970


subject: CHEBI:31970


subject: CHEBI:31970


subject: CHEBI:59204

subject_name: Carbetocin

object_name: Adverse reaction to oxytocic agents


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:3286

subject_name: Cabergoline

object_name: infertility


subject: CHEBI:176381

subject_name: Diosmin


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: leukemia


subject: CHEBI:191174

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: pain agnosia


subject: UMLS:C0358855

object_name: Pain insensitivity


subject: UMLS:C0358855

object_name: Thoracic Diseases


subject: CHEBI:4445

subject_name: Desflurane

object_name: splenectomy; status


subject: CHEBI:44915

subject_name: Propofol


subject: UNII:MZD2VV6EW6

subject_name: PLASMALYTE A

object_name: disorder of acid-base balance


subject: PUBCHEM.COMPOUND:56841986

subject_name: Plasmalyte A


subject: MESH:C414006

subject_name: 23-valent pneumococcal capsular polysaccharide vaccine

object_name: tympanic membrane perforation


subject: MESH:C414006

object_name: Glue ear


subject: MESH:C414006

object_name: infectious otitis media


subject: MESH:C414006

object_name: Acute otitis media


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Pancoast tumor


subject: CHEBI:31355

object_name: Pancoast syndrome


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:18145

subject_name: Vitamin E

object_name: Oral Mucositis


subject: CHEBI:18145

object_name: stomatitis


subject: CHEBI:18145

object_name: oral mucositis


subject: CHEBI:27013

subject_name: Tocopherol


subject: CHEBI:27013


subject: CHEBI:27013


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: pancreatic neoplasm


subject: CHEBI:41879

object_name: exocrine pancreatic carcinoma


subject: CHEBI:41879

object_name: malignant pancreatic neoplasm


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:7773


subject: PUBCHEM.COMPOUND:5300

subject_name: STREPTOZOTOCIN


subject: PUBCHEM.COMPOUND:5300


subject: PUBCHEM.COMPOUND:5300


subject: CHEBI:9288

subject_name: Streptozocin


subject: CHEBI:9288


subject: CHEBI:9288


subject: DRUGBANK:DB14322

subject_name: Coconut oil

object_name: periodontal disorder


subject: DRUGBANK:DB14322

object_name: periodontitis


subject: DRUGBANK:DB14322

object_name: Periodontal inflammation


subject: DRUGBANK:DB14322

object_name: Periodontal Attachment Loss


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1541395


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: metastatic melanoma


subject: UMLS:C3896738

object_name: Hepatic impairment


subject: CHEBI:145372

subject_name: Gilteritinib


subject: CHEBI:149504

object_name: Marfan syndrome


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:64019

subject_name: Nebivolol


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Muscle Pain, CTCAE


subject: PUBCHEM.COMPOUND:2735

object_name: Myalgia


subject: PUBCHEM.COMPOUND:2735

object_name: Arthralgia


subject: PUBCHEM.COMPOUND:2735

object_name: Joint Pain, CTCAE


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:3699

subject_name: Cimetidine

object_name: generalized anxiety disorder


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: cleft lip


subject: CHEBI:3160

object_name: Cleft lip


subject: CHEBI:3160

object_name: cleft palate


subject: CHEBI:3160

object_name: isolated cleft palate


subject: CHEBI:3160

object_name: cleft palate on exam


subject: PUBCHEM.COMPOUND:2269

object_name: mortality


subject: PUBCHEM.COMPOUND:2269

object_name: Bacterial resistance


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: PUBCHEM.COMPOUND:2269

object_name: malaria


subject: PUBCHEM.COMPOUND:2269

object_name: Malaria, antepartum


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955


subject: CHEBI:2955


subject: UMLS:C0021735

subject_name: Viraferon

object_name: ISS Stage III Plasma Cell Myeloma


subject: UMLS:C0021735

object_name: DS Stage III Plasma Cell Myeloma


subject: UMLS:C0021735

object_name: DS Stage II Plasma Cell Myeloma


subject: UMLS:C0021735

object_name: ISS Stage II Plasma Cell Myeloma


subject: UMLS:C0021735

object_name: DS Stage I Plasma Cell Myeloma


subject: UMLS:C0021735

object_name: ISS Stage I Plasma Cell Myeloma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: insomnia


subject: UMLS:C1527137

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C1527137

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: DRUGBANK:DB18476

object_name: glioblastoma


subject: DRUGBANK:DB18476

object_name: Brain Stem Glioblastoma


subject: DRUGBANK:DB18476

object_name: glioma susceptibility 1


subject: UMLS:C4287766

object_name: breast neoplasm


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: pulmonary tuberculosis


subject: GTOPDB:9778

subject_name: cusatuzumab

object_name: acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL4297891

subject_name: CUSATUZUMAB


subject: UMLS:C3827163

subject_name: Cusatuzumab


subject: CHEBI:5558

subject_name: Guanfacine

object_name: endogenous depression


subject: CHEBI:5558

object_name: major depressive disorder


subject: UniProtKB:P09290

subject_name: UL20_VZVD Protein UL20 homolog (sprot)

object_name: type 2 diabetes mellitus


subject: UniProtKB:P09290

object_name: Diabetes


subject: UniProtKB:P09290

object_name: diabetes mellitus


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: CHEBI:6801


subject: UMLS:C3537103

subject_name: Nucleoside Reverse Transcriptase Inhibitor

object_name: adult lymphoma


subject: UMLS:C3537103

object_name: lymphoma


subject: UMLS:C3537103

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:11094963

object_name: Acute exacerbation of chronic obstructive pulmonary disease


subject: CHEBI:87211

subject_name: fluoroquinolone antibiotic


subject: UMLS:C1095897

subject_name: Astragalus preparation

object_name: pancreatic neoplasm


subject: UMLS:C1095897

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1095897

object_name: malignant pancreatic neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: T-Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: blood coagulation disease


subject: CHEBI:31859

subject_name: Modafinil

object_name: cognitive/functional effects


subject: CHEBI:31859

object_name: psychosocial effects of cancer and its treatment


subject: CHEBI:31859

object_name: neurotoxicity


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Locally advanced prostate cancer


subject: CHEBI:4672

subject_name: Docetaxel


subject: UNII:8375F9S90C

subject_name: Pamiparib


subject: UNII:70FJN2AW22


subject: DRUGBANK:DB19133

subject_name: Rezvilutamide


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:233362

object_name: non-small cell lung carcinoma


subject: CHEBI:233362

object_name: colorectal carcinoma


subject: CHEBI:233362

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785

object_name: colorectal cancer


subject: CHEBI:114785


subject: CHEBI:114785


subject: PUBCHEM.COMPOUND:146472812


subject: PUBCHEM.COMPOUND:146472812


subject: PUBCHEM.COMPOUND:146472812


subject: PUBCHEM.COMPOUND:146472812


subject: PUBCHEM.COMPOUND:146472812


subject: DRUGBANK:DB17486


subject: DRUGBANK:DB17486


subject: DRUGBANK:DB17486


subject: DRUGBANK:DB17486


subject: DRUGBANK:DB17486


subject: UMLS:C3896726

subject_name: Lung-targeted Immunomodulator QBKPN


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: bruxism


subject: CHEBI:135967

subject_name: Casopitant

object_name: post operative nausea and vomiting


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: chronic hepatitis C virus infection


subject: CHEBI:10124

subject_name: Zolmitriptan

object_name: cocaine use disorder


subject: UMLS:C4745245

subject_name: Anti-S15 Monoclonal Antibody NC318


subject: UMLS:C4745245


subject: UMLS:C4745245

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4745245

object_name: endometrial cancer


subject: UMLS:C4745245

object_name: uterine corpus cancer


subject: UMLS:C4745245

object_name: endometrial carcinoma


subject: UMLS:C4745245

object_name: urothelial carcinoma


subject: UMLS:C4745245

object_name: transitional cell carcinoma


subject: UMLS:C4745245

object_name: cholangiocarcinoma


subject: UMLS:C4745245

object_name: Childhood Breast Carcinoma


subject: UMLS:C4745245

object_name: breast carcinoma


subject: UMLS:C4745245

object_name: breast cancer


subject: UMLS:C4745245

object_name: lung cancer


subject: UMLS:C4745245

object_name: lung neoplasm


subject: UMLS:C4745245

object_name: lung carcinoma


subject: UMLS:C4745245

object_name: melanoma


subject: GTOPDB:10412

object_name: EXCESS LMW-DNA


subject: UNII:6RQ92PNH8Z


subject: UMLS:C4705323


subject: CHEBI:167638

subject_name: Labetalol

object_name: preeclampsia


subject: CHEBI:167638

object_name: preeclampsia/eclampsia 1


subject: CHEBI:167638

object_name: hypertension, pregnancy-induced


subject: CHEBI:167638

object_name: HELLP syndrome


subject: UNII:56LH93261Y

subject_name: METHYLDOPA


subject: UNII:56LH93261Y


subject: UNII:56LH93261Y


subject: UNII:56LH93261Y


subject: CHEBI:180994


subject: CHEBI:180994


subject: CHEBI:180994


subject: CHEBI:180994


subject: UMLS:C3540782

subject_name: Methyldopa, centrally acting adntiadrenergic agents


subject: UMLS:C3540782


subject: UMLS:C3540782


subject: UMLS:C3540782


subject: CHEBI:61058

subject_name: Methyldopa


subject: CHEBI:61058


subject: CHEBI:61058


subject: CHEBI:61058


subject: CHEBI:7565

subject_name: Nifedipine


subject: CHEBI:7565


subject: CHEBI:7565


subject: CHEBI:9674

subject_name: Triazolam

object_name: dental phobia


subject: MESH:C011664

subject_name: antivitamins K

object_name: Ischemic stroke


subject: MESH:C011664

object_name: atrial septal defect, ostium secundum type


subject: MESH:C011664

object_name: patent foramen ovale


subject: MESH:C011664

object_name: atrial septal aneurysm


subject: MESH:C011664

object_name: migraine


subject: MESH:C011664

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:70746

subject_name: Dabigatran etexilate


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:72296

subject_name: Apixaban


subject: CHEBI:72296


subject: CHEBI:72296


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: HIV infection


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: sudden hearing loss disorder


subject: CHEBI:150712

object_name: sudden sensorineural hearing loss


subject: CHEBI:150712

object_name: Ototoxic hearing loss


subject: CHEBI:150712

object_name: noise induced hearing loss


subject: CHEBI:150712

object_name: Meniere disease


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: UMLS:C1271482

subject_name: MabCampath

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:T472P45MG6

subject_name: Dibotermin alfa

object_name: diabetes mellitus


subject: UNII:T472P45MG6

object_name: hematologic disorder


subject: UNII:T472P45MG6

object_name: blood disease


subject: UNII:T472P45MG6

object_name: hypertension


subject: UNII:T472P45MG6

object_name: Hypertension, CTCAE


subject: UNII:9X7O8V25IT

subject_name: collagenase

object_name: Cellulite


subject: UMLS:C0009053

subject_name: collagenase Clostridium histolyticum


subject: UMLS:C5398049


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: UMLS:C4049021

subject_name: Lidocaine Hydrochloride 20 MG/ML includes Injectable Solution, Injection & Prefilled Syringe

object_name: colorectal cancer


subject: UMLS:C4049021

object_name: colorectal carcinoma


subject: UMLS:C4049021

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: DRUGBANK:DB10989

subject_name: Hepatitis A Vaccine

object_name: hepatitis A


subject: DRUGBANK:DB10989

object_name: hepatitis


subject: UMLS:C0170300

subject_name: Hepatitis A Vaccines


subject: UMLS:C0170300


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: Recurrent disease


subject: CHEBI:22198

object_name: Global Relapse in Viscera


subject: CHEBI:22198

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:22198

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:22198

object_name: Global Relapse


subject: CHEBI:22198

object_name: Global Relapse in Skin


subject: CHEBI:22198

object_name: Global Relapse in Blood


subject: CHEBI:22198

object_name: graft versus host disease


subject: CHEBI:22198

object_name: Engraft failure


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: Community-Acquired Pneumonia


subject: UNII:82JB1524Q6

subject_name: Ombrabulin

object_name: malignant soft tissue neoplasm


subject: UNII:82JB1524Q6

object_name: sarcoma


subject: UMLS:C0910081


subject: UMLS:C0910081


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: IgA Nephropathy


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Withdrawal Symptoms


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: reproductive issues


subject: CHEBI:89324

object_name: Reproductive History


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: cholera


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:63578

subject_name: Iopromide

object_name: pancreatic adenocarcinoma


subject: CHEBI:63578

object_name: pancreatic endocrine carcinoma


subject: CHEBI:63578

object_name: Neuroendocrine carcinoma of pancreas


subject: CHEBI:4466

object_name: septic shock


subject: CHEBI:15367

subject_name: Tretinoin

object_name: esophageal squamous cell carcinoma


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: hyperlipidemia


subject: CHEBI:49040

object_name: hyperlipoproteinemia


subject: CHEBI:49040

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:49040

object_name: Serum lipids high (finding)


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: cerebral amyloid angiopathy


subject: PUBCHEM.COMPOUND:54675783

object_name: ACys amyloidosis


subject: MESH:C547297

subject_name: FSME-IMMUN vaccine

object_name: tick-borne encephalitis


subject: CHEBI:74698

subject_name: Met-Arg


subject: PR:000011407

subject_name: mineralocorticoid receptor


subject: CHEBI:135931

subject_name: Dexlansoprazole

object_name: eosinophilic esophagitis


subject: CHEBI:135931

object_name: Eosinophilic infiltration of the esophagus


subject: CHEBI:135931

object_name: Dysphagia


subject: CHEBI:135931

object_name: Dysphagia, CTCAE


subject: UNII:S9J80L3D1U

subject_name: PELAREOREP

object_name: Plasma cell myeloma refractory


subject: UNII:S9J80L3D1U

object_name: Plasma cell myeloma recurrent


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: HIV infection


subject: UMLS:C3714835

subject_name: Multivitamin Drug Class


subject: UNII:S7RL72610R

subject_name: gossypol acetic acid

object_name: Recurrent Adrenal Cortical Carcinoma


subject: UNII:S7RL72610R

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: UNII:S7RL72610R

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: UNII:S7RL72610R

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: UNII:S7RL72610R

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:35450

subject_name: GOSSYPOL ACETIC ACID


subject: PUBCHEM.COMPOUND:35450


subject: PUBCHEM.COMPOUND:35450


subject: PUBCHEM.COMPOUND:35450


subject: PUBCHEM.COMPOUND:35450


subject: PUBCHEM.COMPOUND:22327742

subject_name: Gosspyl acetate


subject: PUBCHEM.COMPOUND:22327742


subject: PUBCHEM.COMPOUND:22327742


subject: PUBCHEM.COMPOUND:22327742


subject: PUBCHEM.COMPOUND:22327742


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: Injury of diaphragm


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: ankylosing spondylitis


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: chronic obstructive pulmonary disease


subject: UNII:1C6V77QF41

object_name: Paresis


subject: UNII:1C6V77QF41

object_name: Muscle weakness


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C5570980

subject_name: 2.5% Glucose

object_name: Neonatal disorder


subject: CHEBI:9654

subject_name: Trazodone

object_name: Primary Insomnia


subject: UNII:TTT1F11FZB

object_name: endogenous depression


subject: UNII:TTT1F11FZB

object_name: major depressive disorder


subject: UMLS:C5418316

subject_name: Apimostinel


subject: UMLS:C5418316


subject: UNII:1C6V77QF41

object_name: pulmonary tuberculosis


subject: CHEBI:27300


subject: UNII:I60W9520VV

subject_name: Vadadustat

object_name: Anemia in chronic kidney disease


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: non-small cell lung carcinoma


subject: UMLS:C2826372

subject_name: Mammaglobin-A DNA Vaccine

object_name: Carcinoma breast stage IV


subject: DRUGBANK:DB18996

subject_name: Povetacicept


subject: CHEBI:132268

subject_name: Dacomitinib

object_name: lung cancer


subject: CHEBI:132268

object_name: lung neoplasm


subject: CHEBI:132268

object_name: lung carcinoma


subject: CHEBI:132268

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:132268

object_name: EGFR gene mutation


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:40279

subject_name: Allopurinol

object_name: adult lymphoma


subject: CHEBI:40279

object_name: lymphoma


subject: CHEBI:40279

object_name: pediatric lymphoma


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: leukemia


subject: CHEBI:5864

object_name: childhood leukemia


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: Vocal nodules in adults


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Hypoventilation


subject: CHEBI:2790

subject_name: Apramycin

object_name: bacterial infectious disease


subject: UMLS:C5773975


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: HER2 positive breast carcinoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C3827082


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: UMLS:C4733682

subject_name: COVERSIN

object_name: paroxysmal nocturnal hemoglobinuria


subject: UMLS:C5139797

subject_name: Nomacopan


subject: CHEBI:50381

subject_name: Miglustat

object_name: Niemann-Pick disease type C


subject: CHEBI:91083

subject_name: Romiplostim

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:91083

object_name: non-Hodgkin lymphoma


subject: CHEBI:91083

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:91083

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:9130

object_name: mitochondrial disease


subject: CHEBI:8499

subject_name: Propranolol

object_name: liver carcinoma


subject: CHEBI:8499

object_name: Gastroesophageal varices hemorrhage


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:139350422

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: thyroid cancer


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: glucose intolerance


subject: CHEBI:85078

object_name: Impaired glucose tolerance


subject: CHEBI:85078

object_name: Impaired fasting glucose


subject: UNII:DPT0O3T46P

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C5206716

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5206716


subject: UMLS:C5206716


subject: UMLS:C5206716

object_name: Hodgkin Disease


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: infection; viral, enterovirus


subject: UNII:71V0XKJ0WZ

subject_name: PEGTEOGRASTIM

object_name: Chemotherapy induced neutropenia


subject: UNII:71V0XKJ0WZ

object_name: Childhood Solid Neoplasm


subject: UMLS:C4288415

subject_name: Pegteograstim


subject: UMLS:C4288415


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:3035406

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:3035406

object_name: Invasive pulmonary aspergillosis


subject: UMLS:C3896862


subject: UMLS:C3896862


subject: UMLS:C3896862


subject: UNII:1VZO7A0J9S

object_name: macular degeneration


subject: UNII:1VZO7A0J9S

object_name: age-related macular degeneration


subject: UNII:1VZO7A0J9S

object_name: retinitis pigmentosa 30


subject: UNII:1VZO7A0J9S

object_name: choroidal neovascularization


subject: UNII:1VZO7A0J9S

object_name: choroidal neovascularization (physical finding)


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: infertility


subject: UMLS:C0915830


subject: UMLS:C0915830


subject: UMLS:C5690696

subject_name: MitoQ

object_name: ulcerative colitis


subject: UMLS:C5690696

object_name: inflammatory bowel disease 1


subject: UMLS:C3537249

subject_name: D Vitamin

object_name: childhood onset asthma


subject: UMLS:C5421903

subject_name: AirDuo Digihaler

object_name: asthma


subject: UMLS:C5210526

subject_name: ProAir Digihaler


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: triple-negative breast carcinoma


subject: UNII:768FW21J3L

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5966461

subject_name: iDose TR

object_name: OPTN-related open angle glaucoma


subject: UMLS:C5966461

object_name: open-angle glaucoma


subject: UMLS:C5966461

object_name: pigmentary glaucoma


subject: UMLS:C5966461

object_name: exfoliation syndrome, susceptibility to


subject: UMLS:C5966461

object_name: exfoliation syndrome


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: leukemia


subject: UMLS:C5700219

object_name: childhood leukemia


subject: UNII:9X7O8V25IT

subject_name: collagenase

object_name: Edematous skin


subject: UMLS:C0009053

subject_name: collagenase Clostridium histolyticum


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: multiple system atrophy


subject: UNII:3ZY6J6Z6EE

object_name: orthostatic hypotension 1


subject: UNII:3ZY6J6Z6EE

object_name: primary orthostatic hypotension


subject: UNII:3ZY6J6Z6EE

object_name: Neurogenic Orthostatic Hypotension


subject: CHEBI:50692

subject_name: Mifepristone

object_name: pregnancy disorder


subject: CHEBI:50692

object_name: abortion


subject: CHEBI:50692

object_name: Pregnancy loss


subject: CHEBI:50692

object_name: Pregnancy Loss, CTCAE


subject: CHEBI:50692

object_name: Rupture, Spontaneous


subject: CHEBI:50692

object_name: Fetal demise from miscarriage


subject: CHEBI:50692

object_name: Fetal death before 22 weeks with retention of dead fetus


subject: CHEBI:50692

object_name: preterm premature rupture of the membranes


subject: CHEBI:16302

object_name: mortality


subject: CHEBI:16302

object_name: Morbidity


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: glucose intolerance


subject: PUBCHEM.COMPOUND:11306691

object_name: Impaired glucose tolerance


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: lumbar disc herniation


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:367163

subject_name: Darunavir

object_name: cardiovascular disorder


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:63716

subject_name: TENOFOVIR


subject: CHEBI:63716

object_name: HIV infection


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:82960

subject_name: Raltegravir


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174

object_name: Myelodysplasia


subject: CHEBI:191174

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:191174

object_name: childhood myelodysplastic syndrome


subject: CHEBI:191174

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: UNII:2D9N67F58G


subject: UNII:2D9N67F58G

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:2D9N67F58G

object_name: acute myeloid leukemia


subject: UNII:2D9N67F58G

object_name: acute lymphoblastic leukemia


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Cirrhosis


subject: CHEBI:3213

subject_name: Bumetanide

object_name: heart failure


subject: CHEBI:3213

object_name: congestive heart failure


subject: CHEBI:5775

subject_name: Hydralazine


subject: CHEBI:5775


subject: CHEBI:17632

subject_name: Nitrate


subject: CHEBI:17632


subject: CHEBI:6061

subject_name: Isosorbide dinitrate


subject: CHEBI:6061


subject: CHEBI:9637

subject_name: Torasemide


subject: CHEBI:9637


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril


subject: CHEBI:9927

subject_name: Valsartan


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: Allergy


subject: UNII:2P471X1Z11

object_name: History of allergies


subject: UNII:2P471X1Z11

object_name: hypersensitivity reaction disease


subject: UNII:2P471X1Z11

object_name: Emotional hypersensitivity


subject: UNII:2P471X1Z11

object_name: Atopic rhinitis


subject: UNII:2P471X1Z11

object_name: Hay fever


subject: UNII:2P471X1Z11

object_name: rhinitis


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: CHEBI:681569

subject_name: Clofarabine

object_name: myeloproliferative neoplasm


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Childhood Breast Carcinoma


subject: CHEBI:16347

object_name: breast carcinoma


subject: CHEBI:16347

object_name: breast cancer


subject: CHEBI:16347

object_name: Chemotherapeutic Agent Toxicity


subject: CHEBI:16347

object_name: neurotoxicity


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Overweight


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: obesity


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Obesity, CTCAE


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: gestational trophoblastic neoplasm


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: scleritis


subject: CHEBI:71200

object_name: uveitis


subject: CHEBI:71200

object_name: Uveitis, CTCAE


subject: CHEBI:51643

subject_name: 4-pyridyl group

object_name: mild neurocognitive disorder


subject: CHEBI:51643

object_name: mild cognitive impairment


subject: UMLS:C0378071


subject: UMLS:C0378071


subject: UMLS:C1873351

object_name: narcolepsy


subject: UMLS:C1873351

object_name: narcolepsy 1


subject: CHEBI:134709

subject_name: Pitolisant


subject: CHEBI:134709


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C4287690

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C4287690

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820